tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Novo Nordisk (DE:NOV)
XETRA:NOV
Germany Market
NOV
Novo Nordisk
RESEARCH TOOLSreports

Novo Nordisk (NOV) Stock News & Sentiment

Compare
586 Followers
Novo Nordisk: Oral Wegovy Approval Restores Momentum but Competitive Pressures Justify Hold Rating
Premium
Ratings
Novo Nordisk: Oral Wegovy Approval Restores Momentum but Competitive Pressures Justify Hold Rating
1d ago
NVO
Evan Seigerman Issues Hold Rating for Novo Nordisk Amid Revenue Decline Concerns and Market Challenges
Premium
Ratings
Evan Seigerman Issues Hold Rating for Novo Nordisk Amid Revenue Decline Concerns and Market Challenges
29d ago
NVO
Novo Nordisk Faces Challenges Amid Intensifying Competition and Market Pressures
Premium
Ratings
Novo Nordisk Faces Challenges Amid Intensifying Competition and Market Pressures
2M ago
NVO
Cautious Hold Rating on Novo Nordisk Amid Competitive Pressures and Uncertain Growth Prospects
Premium
Ratings
Cautious Hold Rating on Novo Nordisk Amid Competitive Pressures and Uncertain Growth Prospects
2M ago
NVO
Cautious Outlook for Novo Nordisk Amid Uncertain Pipeline Outcomes and Growth Challenges
Premium
Ratings
Cautious Outlook for Novo Nordisk Amid Uncertain Pipeline Outcomes and Growth Challenges
3M ago
NVO
Hold Rating for Novo Nordisk Amid Restructuring and Market Challenges
Premium
Ratings
Hold Rating for Novo Nordisk Amid Restructuring and Market Challenges
3M ago
NVO
Novo Nordisk’s Strategic Restructuring Faces Uncertainty Amid Competitive Pressures
Premium
Ratings
Novo Nordisk’s Strategic Restructuring Faces Uncertainty Amid Competitive Pressures
4M ago
NVO
More DE:NOV News >

NOV News on the Web

Nine of the largest pharma companies ink deals with Trump to lower drug prices
CNBC
Neutral
Wall Street banked on a flurry of deals under Trump in 2025. It wasn't that simple
CNBC
Neutral
This is how exposed European Big Pharma is to the U.S.
CNBC
Neutral
Eli Lilly says obesity pill helps maintain weight loss after patients switch from Wegovy, Zepbound
CNBC
Neutral
Healthy Returns: 2026 will be the year of obesity pills from Novo Nordisk, Eli Lilly
CNBC
Neutral
Novo Nordisk (0QIU) Receives a Buy from Deutsche Bank
TipRanks News
Neutral
High-end Swiss chocolatier Läderach rules out U.S. production despite tariff shock
CNBC
Neutral
Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
CNBC
Neutral

News Score - Last 7 Days

Neutral
DE:NOV
Sector Average
Media Buzz
This Week4 articles
Weekly Average5.25 articles
News Sentiment
This Week50%
Sector Average56%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:NOV’s Media Buzz Sentiment?
4 articles about DE:NOV were published this week. In an average week, 5.25 articles are published.
    What is DE:NOV’s weekly average amount of articles?
    In an average week, 5.25 articles about DE:NOV are published.
      What is DE:NOV’s News Sentiment?
      50% of articles about DE:NOV were positive this week, compared to its sector average of 56%.
        Healthcare Stocks that are Trending in the News
        CYTKCytokinetics
        ATAIATAI Life Sciences
        JNJJohnson & Johnson
        PDEXPro-Dex
        GTBIFGreen Thumb Industries
        Showing the stocks with the most bullish news sentiment over the past week